[ 177 Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors: Primary analysis of the phase 3 randomized NETTER-2 study.

Autor: Singh, Simron, Halperin, Daniel M., Myrehaug, Sten, Herrmann, Ken, Pavel, Marianne, Kunz, Pamela L., Chasen, Beth, Capdevila, Jaume, Tafuto, Salvatore, Oh, Do-Youn, Yoo, Changhoon, Falk, Stephen, Halfdanarson, Thorvardur Ragnar, Folitar, Ilya, Zhang, Yufen, Santoro, Paola, Aimone, Paola, de Herder, Wouter W., Ferone, Diego
Zdroj: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pLBA588-LBA588, 6p
Databáze: Supplemental Index